New insights into atypical Alzheimer's disease in the era of biomarkers

J Graff-Radford, KXX Yong, LG Apostolova… - The Lancet …, 2021 - thelancet.com
Most patients with Alzheimer's disease present with amnestic problems; however, a
substantial proportion, over-represented in young-onset cases, have atypical phenotypes …

Data-driven modelling of neurodegenerative disease progression: thinking outside the black box

AL Young, NP Oxtoby, S Garbarino, NC Fox… - Nature Reviews …, 2024 - nature.com
Data-driven disease progression models are an emerging set of computational tools that
reconstruct disease timelines for long-term chronic diseases, providing unique insights into …

Imaging techniques in Alzheimer's disease: a review of applications in early diagnosis and longitudinal monitoring

WM van Oostveen, ECM de Lange - International journal of molecular …, 2021 - mdpi.com
Background. Alzheimer's disease (AD) is a progressive neurodegenerative disorder
affecting many individuals worldwide with no effective treatment to date. AD is characterized …

[HTML][HTML] How can hearing loss cause dementia?

TD Griffiths, M Lad, S Kumar, E Holmes, B McMurray… - Neuron, 2020 - cell.com
Epidemiological studies identify midlife hearing loss as an independent risk factor for
dementia, estimated to account for 9% of cases. We evaluate candidate brain bases for this …

Lesions without symptoms: understanding resilience to Alzheimer disease neuropathological changes

T Gómez-Isla, MP Frosch - Nature Reviews Neurology, 2022 - nature.com
Since the original description of amyloid-β plaques and tau tangles more than 100 years
ago, these lesions have been considered the neuropathological hallmarks of Alzheimer …

Should artificial intelligence be used in conjunction with Neuroimaging in the diagnosis of Alzheimer's disease?

S Mirkin, BC Albensi - Frontiers in Aging Neuroscience, 2023 - frontiersin.org
Alzheimer's disease (AD) is a progressive, neurodegenerative disorder that affects memory,
thinking, behavior, and other cognitive functions. Although there is no cure, detecting AD …

Diagnosis and management of posterior cortical atrophy

KXX Yong, J Graff-Radford, S Ahmed… - … treatment options in …, 2023 - Springer
Purpose of review The study aims to provide a summary of recent developments for
diagnosing and managing posterior cortical atrophy (PCA). We present current efforts to …

Longitudinal neuroimaging biomarkers differ across Alzheimer's disease phenotypes

I Sintini, J Graff-Radford, ML Senjem, CG Schwarz… - Brain, 2020 - academic.oup.com
Alzheimer's disease can present clinically with either the typical amnestic phenotype or with
atypical phenotypes, such as logopenic progressive aphasia and posterior cortical atrophy …

Sequences of cognitive decline in typical Alzheimer's disease and posterior cortical atrophy estimated using a novel event‐based model of disease progression

NC Firth, S Primativo, E Brotherhood… - Alzheimer's & …, 2020 - Wiley Online Library
Introduction This work aims to characterize the sequence in which cognitive deficits appear
in two dementia syndromes. Methods Event‐based modeling estimated fine‐grained …

[PDF][PDF] Neuroimaging in Alzheimer's disease for early diagnosis: a comprehensive review

S Aramadaka, R Mannam, RS Narayanan, A Bansal… - Cureus, 2023 - cureus.com
Alzheimer's disease (AD) is the most common cause of dementia in the elderly, affecting
roughly half of those over the age of 85. We briefly discussed the risk factors, epidemiology …